Beyond Amyloid: What’s in the Pipeline for Alzheimer’s?

Alzheimer’s drug development now targets tau, neuroinflammation, metabolism, and synaptic dysfunction — expanding beyond amyloid toward precision medicine and combination therapy.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/beyond-amyloid-whats-pipeline-alzheimers-2026a1000jzj?src=rss

Author :

Publish date : 2026-06-15 07:28:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Beyond Amyloid: What’s in the Pipeline for Alzheimer’s?

Patients on GLP-1s: Drugs Aren’t a ‘Magic Bullet’

Can Continuous Blocks Cut Opioid Use After Knee Surgery?

Related Posts

Four JAK Inhibitors Have Positive Late-Stage Trial Results

Nasal Steroids May Not Affect Treatment Response in EoE

We may have finally solved cosmology’s chicken-or-the-egg problem

Can Continuous Blocks Cut Opioid Use After Knee Surgery?

Patients on GLP-1s: Drugs Aren’t a ‘Magic Bullet’

Taboo subjects on the table at women’s health event

Four JAK Inhibitors Have Positive Late-Stage Trial Results

Nasal Steroids May Not Affect Treatment Response in EoE

We may have finally solved cosmology’s chicken-or-the-egg problem

Can Continuous Blocks Cut Opioid Use After Knee Surgery?

Beyond Amyloid: What’s in the Pipeline for Alzheimer’s?

Patients on GLP-1s: Drugs Aren’t a ‘Magic Bullet’

Taboo subjects on the table at women’s health event

‘I won’t have another baby after breastfeeding trauma’

Categories

Archives